Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-14

Clinical Trial Update: Use of Platelet Rich Plasma in the Management of Acute Hamstring Muscle Strain Injury [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating platelet-rich plasma for acute hamstring muscle strain injuries has completed, reporting results from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Aspetar | Conditions: Acute Hamstring Muscle Strain Injury | Phase 2 | Status: COMPLETED